Tuesday, January 10, 2017 9:11:26 PM
Mettrum Health Corp.
January 10, 2017 17:20 ET
Mettrum Health Corp. to Acquire Bodystream Cannabis Clinic Network
TORONTO, ONTARIO--(Marketwired - Jan. 10, 2017) - Mettrum Health Corp. ("Mettrum" or the "Corporation") (TSX VENTURE:MT), a fully integrated medical cannabis producer under the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that it has acquired all of the outstanding shares of 2344823 Ontario Inc., d/b/a Bodystream ("Bodystream"), a leading network of medical cannabis clinics with 14 current locations across Ontario (the "Transaction").
Under the terms of the Transaction, Mettrum paid $1 million in cash and issued 451,596 Mettrum shares from treasury to the current shareholders of Bodystream. These shares are subject to a four-month hold and the Corporation is required to inform the TSX Venture Exchange (the "Exchange") of the Transaction. In addition, Mettrum will issue up to a maximum of 1,505,322 additional shares, over the next three to five years based on Bodystream achieving certain operational milestones.
"We have been working closely with Bodystream for the past two years and they have demonstrated an ability to scale rapidly while maintaining a high level of professional service," said Michael Haines, CEO of Mettrum. "With so many Canadians entering the ACMPR system on a monthly basis and medical cannabis gaining traction as a viable therapeutic option for a variety of symptoms, the time to expand this aspect of our business is now." As previously announced, the Corporation acquired Apollo Applied Research Inc. ("Apollo"), a referral-focused cannabis research clinic based in the Greater Toronto Area. The acquisition of Bodystream complements the Apollo acquisition and expands the reach of the Corporation's clinic network across Ontario, with the opportunity to expand beyond.
"Our mission at Bodystream is to apply cannabis-based therapies that can effectively treat our patients' symptoms," said Brian Warner, President of Bodystream. "Mettrum's physician-centric approach, and commitment to research resonates with our physicians and patients. We look forward to growing with Mettrum and working to develop a variety of services and products that will help improve the quality of life for patients."
Bodystream has operated since 2014 and since then, has earned the trust of an active patient base of approximately 6,000 people.
The Bodystream leadership team will remain on board and will continue operating the business independently as a wholly-owned subsidiary of the Corporation.
Under the terms of the Apollo transaction (which closed on November 15, 2016), in addition to consideration paid by Mettrum on closing, Mettrum agreed to issue up to a maximum of 1,558,752 additional shares, over three to five years, based on Apollo achieving certain operational milestones.
About Mettrum Health Corp
Mettrum Health Corp. is a Tier 1 Industry Issuer listed on the Exchange. Mettrum Ltd., a wholly owned subsidiary of the Corporation, is a Toronto-based company and a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "ACMPR"), which came into effect on August 24, 2016. Mettrum received its first license from Health Canada under the Marihuana for Medical Purposes Regulations (the "MMPR") on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario.
Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its subsidiary, Agripharm Corp., at Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for Mettrum Ltd. at its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. Mettrum is a leading producer and vendor of medical cannabis under the ACMPR system. In addition, through its wholly-owned subsidiary Mettrum Hempworks, Mettrum is also a licensed producer and distributor of industrial cannabis (hemp) products, including Mettrum's functional food line, Mettrum Originals™, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada).
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Mettrum disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.
Contact Information
Mettrum Health Corp.
Ali Mahdavi
Director, Investor Relations
416.962.3300
amahdavi@mettrum.com
Alison George
Argyle Public Relationships
416.968.7311 x230
ageorge@argylepr.com
Please read quickly it could be gone in a minute...
Recent MT News
- ArcelorMittal S.A.: ArcelorMittal publishes its 2023 Integrated Annual Review • GlobeNewswire Inc. • 04/23/2024 01:10:41 PM
- ArcelorMittal S.A.: ArcelorMittal publishes interim update on its company-wide safety audit • GlobeNewswire Inc. • 04/10/2024 02:45:00 PM
- ArcelorMittal publishes convening notice for its Annual General Meeting of shareholders • GlobeNewswire Inc. • 03/29/2024 07:00:00 AM
- ArcelorMittal announces publication of the 2023 statutory financial statements of ArcelorMittal parent company • GlobeNewswire Inc. • 03/27/2024 07:15:00 PM
- ArcelorMittal publishes revised analyst model per new segmental reporting • GlobeNewswire Inc. • 03/27/2024 09:30:00 AM
- ArcelorMittal S.A.: ArcelorMittal announces Kleber Silva to be new CEO of ArcelorMittal Mining • GlobeNewswire Inc. • 03/19/2024 09:00:00 AM
- Intel Loses Pentagon Funding, Shell Plans 20% Business Team Reduction, and Latest News • IH Market News • 03/13/2024 11:02:03 AM
- ArcelorMittal S.A.: ArcelorMittal acquires strategic stake in Vallourec • GlobeNewswire Inc. • 03/12/2024 09:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/29/2024 06:50:20 PM
- ArcelorMittal S.A.: ArcelorMittal announces the publication of its 2023 annual report • GlobeNewswire Inc. • 02/28/2024 08:40:00 PM
- ArcelorMittal S.A.: ArcelorMittal publishes its Annual Report 2023 on Form 20-F • GlobeNewswire Inc. • 02/28/2024 07:55:00 PM
- Statement re Acciaierie d’Italia being placed into extraordinary administration • GlobeNewswire Inc. • 02/20/2024 04:59:58 PM
- Arm Achieves Record Revenue, PayPal Shares Plummet by More Than 9%, and Latest Updates • IH Market News • 02/08/2024 11:10:06 AM
- ArcelorMittal S.A.: ArcelorMittal reports fourth quarter and full year 2023 results • GlobeNewswire Inc. • 02/08/2024 06:00:00 AM
- ArcelorMittal announces the publication of its fourth quarter and full year 2023 sell-side analyst consensus figures • GlobeNewswire Inc. • 02/05/2024 09:15:00 PM
- ArcelorMittal to See Carbon-Permit Surplus During Dunkirk Plant Transition -- OPIS Analysis • Dow Jones News • 01/19/2024 07:09:00 PM
- Wall Street Highlights: Macy’s Announces Job Cuts, iRobot Shares Plummet Due to Planned Acquisition Block, and More • IH Market News • 01/19/2024 11:09:24 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/22/2023 11:10:51 AM
- ArcelorMittal engages dss+ to conduct group-wide safety audit • GlobeNewswire Inc. • 12/22/2023 07:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/21/2023 08:02:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/15/2023 04:18:19 PM
- ArcelorMittal Sells Temirtau Operations to Kazakh Government for $286 Million -- Update • Dow Jones News • 12/08/2023 01:03:00 PM
- Apple Boosts Vietnam Production, Broadcom Revenue Miss, Stellantis Job Cuts – Latest Updates • IH Market News • 12/08/2023 11:23:53 AM
- ArcelorMittal Sells Temirtau Assets to Kazakh Government for $286 Million • Dow Jones News • 12/08/2023 09:54:00 AM
- ArcelorMittal completes sale of ArcelorMittal Temirtau • GlobeNewswire Inc. • 12/08/2023 07:40:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM